Wang Lin, Wang Yu, Wu Hao, Zhu Xiaoming, Yu Jiyun, Jiang Jianli, Yan Jinqi
Cell Engineering Research Center, Fourth Military Medical University, Xi'an 710032, China.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2013 May;29(5):469-72.
To construct a eukaryotic expression plasmid harboring HBV fusion antigen gene, and to express it in 293T cells.
The HBV fusion gene fragment was amplified by PCR from the plasmid pVAX1-HBV containing HBV fusion gene. After purified, the product was cloned into pMD18-T vector. The recombinant plasmid was confirmed by endonuclease digestion and sequencing analysis, and then subcloned into eukaryotic expression vector pIRES-neo. Then the recombinant expression plasmid pIRES-neo-HBAg was transfered into 293T cells by Lipofectamine(TM); 2000. The expression of HBV fusion antigen was identified by Western blotting, flow cytometry and immunofluorescence cytochemistry.
The eukaryotic expression vector pIRES-neo-HBAg was constructed successfully. The expression of fusion antigen could be detected in the pIRES-neo-HBAg transfected 293T cells by Western blotting, immunofluorescence cytochemistry and flow cytometry.
The eukaryotic expression plasmid pIRES-neo-HBAg is successfully constructed and the fusion antigen is expressed in 293T cells.